pediatric acute lymphoblastic leukemia

Role of Human Granulocyte Colony-Stimulating Factor (rHuG-CSF) in Myelosuppressive Therapy-Induced Febrile Neutropenia in Children with Acute Lymphoblastic Leukaemia: Real World Data from Central India
Growth Pattern in Pediatric Acute Lymphoblastic Leukemia Survivors
Periodically intensification during maintenance chemotherapy is effective in pediatric acute lymphoblastic leukemia
Unplanned Hospital Visits of Pediatric Acute Lymphoblastic Leukemia (ALL) patients during Maintenance Phase of Chemotherapy- a tertiary care center experience from a newly established pediatric oncology service in Saudi Arabia
Results of the program treatment of acute lymphoblastic leukemia in children in Uzbekistan according to the ALL-MB-2015 protocol
Socialization domain of adaptive functioning between children with Acute Lymphoblastic Leukemia and their healthy peers through VABS-III
Clinical Profile and Patterns of Central Nervous System Relapse in Pediatric Acute Lymphoblastic Leukemia – a Single Centre Experience
Improving the outcome of pediatric ALL by transitioning from nonuniform chemotherapy regimens to a uniform multicentric protocol: A comprehensive experience from an Indian center on the ICiCLe protocol
Molecular Profile of Pediatric Acute Lymphoblastic Leukemia: A retrospective study from Tertiary Care Centre of Kashmir
Incidence of PEG-Asparaginase-Induced Pancreatitis in Children During Acute Lymphoblastic Leukemia Treatment: A Multicenter Study
Outcomes of Patients Diagnosed with Acute Lymphoblastic Leukemia in the Years 2020-2022 at a Tertiary Hospital in the Philippines: The Philippine General Hospital Experience with the Covid-19 Pandemic
Frequency and Factors Influencing 6-Mercaptopurine Induced Grade 4 Neutropenia in Children with Acute Lymphoblastic Leukemia during Maintenance Therapy in Bangabandhu Sheikh Mujib Medical University